Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
11.03.Gilead launches patient hub to 'expose' realities of living with metastatic breast cancer
11.03.Incyte's JAK cream Opzelura proves its worth in treating hidradenitis suppurativa in midstage study
11.03.Legend CEO offers preview of high-stakes FDA adcomm for J&J-partnered Carvykti
11.03.Viatris' launch plans scuttled as FDA rebuffs long-acting MS drug from partner Mapi
11.03.Eli Lilly, with Oscars in its sights, calls out stars who use GLP-1 drugs to fit in a dress or tux
11.03.Bluebird bio inks first Medicaid coverage agreement for sickle cell gene therapy, signing on with Michigan
11.03.Sun Pharma issues recall of gout drug due to microbial contamination
08.03.Novo's obesity superstar Wegovy wins FDA nod to cut cardio risks in key label expansion
08.03.Exact Sciences gets in on the March Madness, drafting former pro Mashburn for colon cancer awareness campaign
08.03.GSK, facing Shingrix penetration plateau, doubles funding for adult vaccine uptake programs
08.03.After trial failure, will Amylyx pull ALS drug Relyvrio off the market?
08.03.Bristol Myers, overshadowed by ADC rival, wins FDA nod for Opdivo combo in bladder cancer
08.03.PhRMA seeks to revive Medicare price negotiations lawsuit, blasts Biden's request for IRA expansion
07.03.Eli Lilly flags bacteria, impurity concerns in fake and compounded versions of popular GLP-1 meds
07.03.Despite pharma growth, Merck KGaA's CDMO slowdown plays into company's overall sales decline
07.03.Despite Leqembi's launch pains, Eisai projects Alzheimer's med will reach $8.8B in the long run
07.03.Boehringer Ingelheim cuts monthly out-of-pocket inhaler prices to $35 for US patients
07.03.After withdrawal, GSK touts another Blenrep combo win as analysts build blockbuster case for the myeloma ADC
07.03.UCB ups the ante with CDMO Samsung Biologics, signing $353M deal
06.03.Not-so-dirty words: Dr. Pimple Popper appears in another Sun Pharma ad to open up acne talk
06.03.WHO flags increasing resistance to GSK's HIV med Tivicay in some countries
06.03.Growing Almac boosts capacity for manufacturing peptides and packaging commercial products
06.03.AstraZeneca pledges £650M in UK investments to boost vaccine capabilities, expand near HQ
06.03.Argonaut's journey continues with $45M in new financing for facility expansion
06.03.Everlywell flushes away 'stool stigma' to bump up at-home colon cancer screening rates